Cargando…

SIX4 upregulates IDH1 and metabolic reprogramming to promote osteosarcoma progression

Metabolism reprogramming plays an important role in tumorigenesis and osteosarcoma metastasis. Sine oculis homeobox 4 (SIX4) is reported to be a key transcription factor that is involved in glycolysis reprogramming of cancer cells. However, the role of SIX4 in osteosarcoma progression remains unknow...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Bing, Dang, Xiaoqian, Duan, Jiafeng, Zhang, Guangyang, Zhang, Jia, Song, Qichun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9843517/ https://www.ncbi.nlm.nih.gov/pubmed/36601689 http://dx.doi.org/10.1111/jcmm.17650

Ejemplares similares

AHA1 upregulates IDH1 and metabolic activity to promote growth and metastasis and predicts prognosis in osteosarcoma
por: Zheng, Diwei, et al.
Publicado: (2021)

Molecular Imaging of Metabolic Reprograming in Mutant IDH Cells
por: Viswanath, Pavithra, et al.
Publicado: (2016)

Metabolic Reprogramming in Mutant IDH1 Glioma Cells
por: Izquierdo-Garcia, Jose L., et al.
Publicado: (2015)

IDH2 stabilizes HIF‐1α‐induced metabolic reprogramming and promotes chemoresistance in urothelial cancer
por: Shigeta, Keisuke, et al.
Publicado: (2023)

Upregulation of ALDH1B1 promotes tumor progression in osteosarcoma
por: Wang, Xin, et al.
Publicado: (2017)

METTL16 promotes glycolytic metabolism reprogramming and colorectal cancer progression
por: Wei, Wei, et al.
Publicado: (2023)

Epigenetic Reprogramming for Targeting IDH-Mutant Malignant Gliomas
por: Park, Jong-Whi, et al.
Publicado: (2019)

The expression and significance of IDH1 and p53 in osteosarcoma
por: Hu, Xiang, et al.
Publicado: (2010)

Causal relationships between rheumatism and dyslipidemia: A two-sample Mendelian randomization study
por: Zhang, Guangyang, et al.
Publicado: (2022)

circATP2A2 promotes osteosarcoma progression by upregulating MYH9
por: Cao, Xin, et al.
Publicado: (2021)

The Long Non-Coding RNA IDH1-AS1 Promotes Prostate Cancer Progression by Enhancing IDH1 Enzyme Activity
por: Wu, Shuo, et al.
Publicado: (2020)

Metabolic Profiling of IDH Mutation and Malignant Progression in Infiltrating Glioma
por: Jalbert, Llewellyn E., et al.
Publicado: (2017)

Role of mesenchymal stem cells in osteosarcoma and metabolic reprogramming of tumor cells
por: Bonuccelli, Gloria, et al.
Publicado: (2014)

Pramlintide: A Novel Therapeutic Approach for Osteosarcoma through Metabolic Reprogramming
por: Yang, Yuanzheng, et al.
Publicado: (2022)

LncRNA TUG1 is upregulated and promotes cell proliferation in osteosarcoma
por: Yun-Bo, Feng, et al.
Publicado: (2016)

Exosomes derived from M2 macrophages induce angiogenesis to promote wound healing
por: Lyu, Leifeng, et al.
Publicado: (2022)

IDH1 and IDH2 mutations in myelodysplastic syndromes and role in disease progression
por: DiNardo, Courtney D, et al.
Publicado: (2015)

Cellular senescence-driven transcriptional reprogramming of the MAFB/NOTCH3 axis activates the PI3K/AKT pathway and promotes osteosarcoma progression
por: Zhang, Zhenhao, et al.
Publicado: (2023)

Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
por: Wu, Dapeng, et al.
Publicado: (2017)

LPCAT1 reprogramming cholesterol metabolism promotes the progression of esophageal squamous cell carcinoma
por: Tao, Mingyue, et al.
Publicado: (2021)

Editorial: Metabolic reprogramming and cancer progression
por: Yin, Qinan, et al.
Publicado: (2022)

The splicing factor YBX1 promotes the progression of osteosarcoma by upregulating VEGF(165) and downregulating VEGF(165b)
por: Quan, Bingxuan, et al.
Publicado: (2023)

PAX5-induced upregulation of IDH1-AS1 promotes tumor growth in prostate cancer by regulating ATG5-mediated autophagy
por: Zhang, Nan, et al.
Publicado: (2019)

Rac1 promotes the reprogramming of glucose metabolism and the growth of colon cancer cells through upregulating SOX9
por: Liang, Jiaxin, et al.
Publicado: (2022)

Upregulation Of circMMP9 Promotes Osteosarcoma Progression Via Targeting miR-1265/CHI3L1 Axis
por: Pan, Guangjie, et al.
Publicado: (2019)

EPEL promotes the migration and invasion of osteosarcoma cells by upregulating ROCK1
por: Chen, Shunguang, et al.
Publicado: (2019)

Upregulation of SOX9 in osteosarcoma and its association with tumor progression and patients’ prognosis
por: Zhu, Haibo, et al.
Publicado: (2013)

IDH1: Linking Metabolism and Epigenetics
por: Raineri, Silvia, et al.
Publicado: (2018)

miR-23b-3p suppressing PGC1α promotes proliferation through reprogramming metabolism in osteosarcoma
por: Zhu, Ran, et al.
Publicado: (2019)

CDKL3 promotes osteosarcoma progression by activating Akt/PKB
por: He, Aina, et al.
Publicado: (2020)

Research progress of circRNA in malignant tumour metabolic reprogramming
por: Geng, Yikun, et al.
Publicado: (2023)

Intramedullary core decompression combined with endoscopic intracapsular decompression and debridement for pre-collapse non-traumatic osteonecrosis of the femoral head
por: Zhao, Yan, et al.
Publicado: (2023)

Linking Metabolic Reprogramming, Plasticity and Tumor Progression
por: Shuvalov, Oleg, et al.
Publicado: (2021)

Tumor metabolic reprogramming in lung cancer progression
por: Li, Xin, et al.
Publicado: (2022)

Research progress in the mechanism and treatment of osteosarcoma
por: Bian, Jichao, et al.
Publicado: (2023)

Starvation induced autophagy promotes the progression of bladder cancer by LDHA mediated metabolic reprogramming
por: Li, Tinghao, et al.
Publicado: (2021)

CBMS-1 Targeting amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas
por: Ohba, Shigeo, et al.
Publicado: (2021)

Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis
por: Sheng, Gaohong, et al.
Publicado: (2023)

Interleukin-6 upregulates SOX18 expression in osteosarcoma
por: Wu, Zhong, et al.
Publicado: (2017)

Hypoxia-induced GBE1 expression promotes tumor progression through metabolic reprogramming in lung adenocarcinoma
por: Li, Lifeng, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4tr5nepvpts49bk6ai6srecgmf